Market Overview
The bioactive peptide market consists of peptides derived
from various sources such as milk, egg, fish, and plants. These peptides help
in regulating various physiological functions in the body including immunity,
blood pressure control, hormones, cell signaling, and digestive functions. With
growing awareness about the health benefits of bioactive peptides, they are
increasingly being added to various food and beverage products. Some of the
major applications of bioactive peptides include sports nutrition, clinical
nutrition, infant formula, dairy products, and meat products.
The global bioactive peptide market is estimated to be
valued at US$ 11.29 Bn in 2024 and
is expected to exhibit a CAGR of 8.0%
over the forecast period of 2024 to 2031.
Key Takeaways
Key players operating in the bioactive peptide market are Archer Daniels
Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd.,
Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy,
GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC,
vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO
Forschung und Entwicklung GmbH, and BIONANOPLUS. The key opportunity in the
market lies in the development of new applications of bioactive peptides in
various therapeutic areas. Many companies are focusing on global expansion by
establishing production and distribution networks across different geographies
to tap the opportunities in emerging nations.
Market Drivers
The rising health awareness has led more consumers to opt for food products
fortified with bioactive peptides due to their associated health benefits. With
growing research, new bioactive peptides are being identified that have
therapeutic applications in conditions like high blood pressure, obesity,
osteoporosis, etc. further driving their demand.
Market Restrains
The high production cost of
Bioactive
Peptide Market Demand compared to regular protein ingredients is a
major challenge. Since bioactive peptides are derived through enzymatic
hydrolysis, it is a complex process that increases costs. Additionally, limited
consumer awareness about the benefits of bioactive peptides in developing
countries is another factor restraining market growth.
Segment
Analysis
The bioactive peptide market is dominated by collagen
peptides, which is projected to grow at the highest CAGR during the forecast
period. Collagen peptides help in supporting skin, joint, and gut health. Their
bioavailability and absorption rate in the body is also very high. Higher
absorption leads to faster and observable results, which is driving the demand
for collagen peptides. Whey protein-derived bioactive peptides is another major
segment. They have various health benefits like improved immunity,
cardiovascular health, weight management, muscle building, etc. Rising awareness
about protein supplementation is favoring the growth of this segment.
Global Analysis
North America dominates the global bioactive peptide market
currently due to high consumer awareness about nutritional and health benefits
of bioactive peptides. Increasing adoption of dietary supplements to boost
health and relieve joint pain/discomfort in aging population is driving the
market in the region. Europe is also a significant regional market attributed
to growing vegan population and preference for plant-based peptides as meat
alternative. Asia Pacific is estimated to be the fastest growing market during
the forecast period owing to rising middle class, increasing incomes, and
growing health consciousness. Population in countries like China, Japan, and
India are actively consuming bioactive peptides to prevent lifestyle diseases.
Get More Insights on- Bioactive
Peptide Market
Comments
Post a Comment